000 | 01907 a2200481 4500 | ||
---|---|---|---|
005 | 20250513202657.0 | ||
264 | 0 | _c20000412 | |
008 | 200004s 0 0 eng d | ||
022 | _a1058-4838 | ||
024 | 7 |
_a10.1086/313669 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcNeil, S A | |
245 | 0 | 0 |
_aSuccessful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin). _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cFeb 2000 |
||
300 |
_a403-4 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAcetamides _xadministration & dosage |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 |
_aBacteremia _xdiagnosis |
650 | 0 | 4 | _aBone Marrow Transplantation |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
650 | 0 | 4 |
_aEnterococcus faecium _xdrug effects |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdiagnosis |
650 | 0 | 4 | _aLinezolid |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOxazoles _xadministration & dosage |
650 | 0 | 4 | _aOxazolidinones |
650 | 0 | 4 | _aPostoperative Complications |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aVancomycin Resistance |
650 | 0 | 4 |
_aVirginiamycin _xtherapeutic use |
700 | 1 | _aClark, N M | |
700 | 1 | _aChandrasekar, P H | |
700 | 1 | _aKauffman, C A | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 30 _gno. 2 _gp. 403-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1086/313669 _zAvailable from publisher's website |
999 |
_c10625794 _d10625794 |